34951366|t|Control of beta-Site Amyloid Precursor Protein-Cleaving Enzyme-1 Expression by Protein Kinase C-lambda/iota and Nuclear Factor kappa-B.
34951366|a|Betaackground: beta-Amyloid precursor protein-cleaving enzyme-1 (BACE1) initiates the production of Abeta-peptides that form Abeta-plaque in Alzheimer's disease. METHODS: Reportedly, acute insulin treatment in normal mice, and hyperinsulinemia in high-fat-fed (HFF) obese/diabetic mice, increase BACE1 activity and levels of Abeta-peptides and phospho- -thr-231-tau in the brain; moreover, these effects are blocked by PKC-lambda/iota inhibitors. However, as chemical inhibitors may affect unsuspected targets, we presently used knockout methodology to further examine PKC-lambda/iota requirements. We found that total-body heterozygous PKC-lambda knockout reduced acute stimulatory effects of insulin and chronic effects of hyperinsulinemia in HFF/obese/diabetic mice, on brain PKC-lambda activity and production of Abeta1-40/42 and phospho-thr-231-tau. This protection in HFF mice may reflect that hepatic PKC-lambda haploinsufficiency prevents the development of glucose intolerance and hyperinsulinemia. RESULTS: On the other hand, heterozygous knockout of PKC-lambda markedly reduced brain levels of BACE1 protein and mRNA, and this may reflect diminished activation of nuclear factor kappa-B (NFkappaB), which is activated by PKC-lambda and increases BACE1 and proinflammatory cytokine transcription. Accordingly, whereas intravenous administration of aPKC inhibitor diminished aPKC activity and BACE1 levels by 50% in the brain and 90% in the liver, nasally-administered inhibitor reduced aPKC activity and BACE1 mRNA and protein levels by 50-70% in the brain while sparing the liver. Additionally, 24-hour insulin treatment in cultured human-derived neurons increased NFkappaB activity and BACE1 levels, and these effects were blocked by various PKC-lambda/iota inhibitors. CONCLUSION: PKC-lambda/iota controls NFkappaB activity and BACE1 expression; PKC-lambda/iota inhibitors may be used nasally to target brain PKC-lambda/iota or systemically to block both liver and brain PKC-lambda/iota, to regulate NFkappaB-dependent BACE1 and proinflammatory cytokine expression.
34951366	11	64	beta-Site Amyloid Precursor Protein-Cleaving Enzyme-1	Gene	23821
34951366	79	102	Protein Kinase C-lambda	Gene	18759
34951366	112	134	Nuclear Factor kappa-B	Gene	18033
34951366	201	206	BACE1	Gene	23821
34951366	236	241	Abeta	Gene	11820
34951366	261	266	Abeta	Gene	11820
34951366	277	296	Alzheimer's disease	Disease	MESH:D000544
34951366	325	332	insulin	Gene	3630
34951366	353	357	mice	Species	10090
34951366	363	379	hyperinsulinemia	Disease	MESH:D006946
34951366	402	407	obese	Disease	MESH:D009765
34951366	408	416	diabetic	Disease	MESH:D003920
34951366	417	421	mice	Species	10090
34951366	432	437	BACE1	Gene	23821
34951366	461	466	Abeta	Gene	11820
34951366	480	498	phospho- -thr-231-	Chemical	-
34951366	555	565	PKC-lambda	Gene	18759
34951366	705	715	PKC-lambda	Gene	18759
34951366	773	783	PKC-lambda	Gene	18759
34951366	830	837	insulin	Gene	3630
34951366	861	877	hyperinsulinemia	Disease	MESH:D006946
34951366	885	890	obese	Disease	MESH:D009765
34951366	891	899	diabetic	Disease	MESH:D003920
34951366	900	904	mice	Species	10090
34951366	915	925	PKC-lambda	Gene	18759
34951366	1014	1018	mice	Species	10090
34951366	1044	1054	PKC-lambda	Gene	18759
34951366	1102	1121	glucose intolerance	Disease	MESH:D018149
34951366	1126	1142	hyperinsulinemia	Disease	MESH:D006946
34951366	1197	1207	PKC-lambda	Gene	18759
34951366	1241	1246	BACE1	Gene	23821
34951366	1311	1333	nuclear factor kappa-B	Gene	18033
34951366	1335	1343	NFkappaB	Gene	18033
34951366	1368	1378	PKC-lambda	Gene	18759
34951366	1393	1398	BACE1	Gene	23821
34951366	1538	1543	BACE1	Gene	23621
34951366	1650	1655	BACE1	Gene	23621
34951366	1750	1757	insulin	Gene	3630
34951366	1780	1785	human	Species	9606
34951366	1812	1820	NFkappaB	Gene	4790
34951366	1834	1839	BACE1	Gene	23621
34951366	1890	1900	PKC-lambda	Gene	18759
34951366	1930	1940	PKC-lambda	Gene	18759
34951366	1955	1963	NFkappaB	Gene	4790
34951366	1977	1982	BACE1	Gene	23821
34951366	1995	2005	PKC-lambda	Gene	18759
34951366	2058	2068	PKC-lambda	Gene	18759
34951366	2120	2130	PKC-lambda	Gene	18759
34951366	2149	2157	NFkappaB	Gene	18033
34951366	2168	2173	BACE1	Gene	23821
34951366	Association	MESH:D006946	18759
34951366	Association	MESH:D018149	18759
34951366	Positive_Correlation	23821	3630
34951366	Positive_Correlation	11820	23821
34951366	Positive_Correlation	18033	18759
34951366	Association	MESH:D000544	11820
34951366	Association	18759	3630
34951366	Negative_Correlation	18759	4790
34951366	Positive_Correlation	MESH:D006946	23821
34951366	Positive_Correlation	MESH:D006946	11820
34951366	Positive_Correlation	18033	23821
34951366	Positive_Correlation	23621	3630
34951366	Association	MESH:D000544	23821
34951366	Association	18759	23821
34951366	Association	MESH:D009765	18759
34951366	Positive_Correlation	3630	4790
34951366	Positive_Correlation	11820	3630
34951366	Association	MESH:D003920	18759

